Skip to main content

Antigluten Therapy

  • Living reference work entry
  • First Online:
  • 123 Accesses

Definition

Antigluten therapy is the elimination of gluten from the body by dieting and/or supplemental enzymes. This entry will examine enzyme supplements that break down gluten. (For elimination diets, see “Gluten-Free Diet.”)

Historical Background

In 1979, Jaak Panksepp hypothesized that the symptoms of autism may be caused by an opiate excess, although he was unsure how such an excess might come about. Starting in the 1980s, some investigators reported abnormal peptide concentrations in the urine of children with autism and proposed that enzyme deficiencies caused this abnormality (Trygstad et al. 1980; Reichelt et al. 1981, 1990). Additionally, these investigators speculated that the abnormal peptide concentrations reflected abnormal levels of opioid peptides in the brain (Trygstad et al. 1980; Reichelt et al. 1981). More recently, Andrew Wakefield (Wakefield et al. 1998) described intestinal abnormalities in several children with autism and hypothesized that this abnormality...

This is a preview of subscription content, log in via an institution.

References and Readings

  • Brudnack, M. A., Rimland, B., Kerry, R. E., Dailey, M., Taylor, R., Stayton, B., et al. (2002). Enzyme-based therapy for autism spectrum disorders – Is it worth another look? Medical Hypotheses, 58, 422–428.

    Article  Google Scholar 

  • Buie, T., Campbell, D. B., Fuchs III, G. J., Furuta, G. T., Levy, J., Van de Water, J., et al. (2010). Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: A consensus report. Pediatrics, 125, S1–S18.

    Article  Google Scholar 

  • Fernell, E., Fagerberg, U. L., & Hellstrom, P. M. (2007). No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide. Acta Paediatrica, 96, 1076–1079.

    Article  Google Scholar 

  • Fitzgerald, M., Woods, M., & Matthews, P. (1999). Investigation of possible links between autism and celiac disease. Autism, 3, 193–195.

    Article  Google Scholar 

  • Hunter, L. C., O’Hare, A., Herron, W. J., Fisher, L. A., & Jones, G. E. (2003). Opioid peptides and dipeptidyl peptidase in autism. Developmental Medicine and Child Neurology, 45, 121–128.

    Article  Google Scholar 

  • Lucarelli, S., Frediani, T., Zingoni, A. M., Ferruzzi, F., Giardini, O., Quinteri, F., et al. (1995). Food allergy and infantile autism. Panminerva Medica, 37, 137–141.

    PubMed  Google Scholar 

  • McCarthy, D. M., & Coleman, M. (1979). Response of intestinal mucosa to gluten challenge in autistic subjects. The Lancet, 314, 877–878.

    Article  Google Scholar 

  • Munasinghe, S. A., Oliff, C., Finn, J., & Wray, J. A. (2010). Digestive enzyme supplementation for autism spectrum disorders: A double-blind randomized controlled trial. Journal of Autism and Developmental Disorders, 40(9), 1131–1138.

    Article  Google Scholar 

  • Panksepp, J. (1979). A neurochemical theory of autism. Trends in Neurosciences, 2, 174–177.

    Article  Google Scholar 

  • Reichelt, K. L., Ekrem, J., & Scott, H. (1990). Gluten, milk proteins and autism: Dietary intervention effects on behaviour and peptide secretion. Journal of Applied Nutrition, 42, 1–11.

    Google Scholar 

  • Reichelt, K. L., Hole, K., Hamberger, A., Saelid, G., Edminson, P. D., Braestrup, C. B., et al. (1981). Biologically active peptide-containing fractions in schizophrenia and childhood autism. Advances in Biochemical Psychopharmacology, 28, 627–643.

    PubMed  Google Scholar 

  • Sandhu, B., Steer, C., Golding, J., & Emond, A. (2009). The early stool patterns of young children with autistic spectrum disorder. Archives of Disease in Childhood, 94, 497–500.

    Article  Google Scholar 

  • Trygstad, O. E., Reichelt, K. L., Foss, I., Edminson, P. D., Selid, G., Bremer, J., et al. (1980). Patterns of peptides and protein-associated-peptide complexes in psychiatric disorders. British Journal of Psychiatry, 136, 59–72.

    Article  Google Scholar 

  • Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., et al. (1998). Illeal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet, 351, 637–641.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Madison Pilato .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media LLC

About this entry

Cite this entry

Pilato, M. (2016). Antigluten Therapy. In: Volkmar, F. (eds) Encyclopedia of Autism Spectrum Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6435-8_1285-3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6435-8_1285-3

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6435-8

  • Online ISBN: 978-1-4614-6435-8

  • eBook Packages: Springer Reference Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences

Publish with us

Policies and ethics